372694001: Erythromycin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Substance with macrolide structure and antibacterial mechanism of action (substance)\Erythromycin (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Substance with macrolide structure and antibacterial mechanism of action (substance)\Erythromycin (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Lactone (substance)\Macrolide (substance)\Substance with macrolide structure and antibacterial mechanism of action (substance)\Erythromycin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Erythromycin (substance)	Is a	Substance with macrolide structure and antibacterial mechanism of action (substance)	true	Inferred relationship	Some
Erythromycin (substance)	Is a	Antiinfektiøst middel til huden	false	Inferred relationship	Some
Erythromycin (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some
Erythromycin (substance)	Is a	Macrolide (substance)	false	Inferred relationship	Some
Erythromycin (substance)	Is a	Antibacterial	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Erythromycin estolate	Is a	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin ethylsuccinate (substance)	Is a	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin stearate	Is a	False	Erythromycin (substance)	Inferred relationship	Some
erythromycinpræparat til oftalmisk anvendelse	Is a	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin lactobionate	Is a	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin gluceptate	Is a	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin phosphate	Is a	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin measurement (procedure)	Component	True	Erythromycin (substance)	Inferred relationship	Some	1
Erythromycin poisoning	Causative agent	True	Erythromycin (substance)	Inferred relationship	Some	1
Accidental erythromycin poisoning	Causative agent	False	Erythromycin (substance)	Inferred relationship	Some
Intentional erythromycin poisoning	Causative agent	False	Erythromycin (substance)	Inferred relationship	Some
forgiftning med erythromycin, uvist med hvilken hensigt	Causative agent	False	Erythromycin (substance)	Inferred relationship	Some	1
Erythromycin adverse reaction	Causative agent	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin overdose	Causative agent	True	Erythromycin (substance)	Inferred relationship	Some	1
Accidental erythromycin overdose	Causative agent	True	Erythromycin (substance)	Inferred relationship	Some	1
Intentional erythromycin overdose	Causative agent	True	Erythromycin (substance)	Inferred relationship	Some	1
overdosis af erythromycin, uvist med hvilken hensigt	Causative agent	False	Erythromycin (substance)	Inferred relationship	Some	1
Product containing erythromycin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Erythromycin (substance)	Inferred relationship	Some	1
Erythromycin 250 mg gastro-resistant oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
erythromycin 125 mg/5 ml sukkerfri suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
erythromycin 250 mg/5 ml sukkerfri suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
erythromycin 500 mg/5 ml sukkerfri suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 25 milligram/1 milliliter conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 100 milligram/1 milliliter conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin [2]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin [skin]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
erythromycin 3 % i benzoylperoxid gel til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Erythromycin (substance)	Inferred relationship	Some	1
Erythromycin-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Erythromycin (substance)	Inferred relationship	Some	1
erythromycin til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Product containing precisely erythromycin 333 milligram/1 each gastro-resistant oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
erythromycin polymercoatet 333 mg partikeltablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
erythromycin polymercoatet 500 mg partikeltablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
erythromycin kapsel med modificeret udløsning a 250 mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin 2% gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
erythromycin 2 % salve	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Product containing precisely erythromycin 15 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin 5 mg/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin 20mg/mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin 500 mg gastro-resistant oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
benzoylperoxid 50 mg + erythromycin 30 mg gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
erythromycinethylsuccinat 200 mg + sulfisoxazolacetyl 600 mg oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Allergy to erythromycin	Causative agent	False	Erythromycin (substance)	Inferred relationship	Some
Product containing erythromycin and isotretinoin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing erythromycin and tretinoin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing erythromycin and zinc acetate (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing benzoyl peroxide and erythromycin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
erythromycin 250 mg enterogranulat i kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Accidental erythromycin poisoning	Causative agent	True	Erythromycin (substance)	Inferred relationship	Some	1
Intentional erythromycin poisoning	Causative agent	True	Erythromycin (substance)	Inferred relationship	Some	1
Erythromycin adverse reaction (disorder)	Causative agent	True	Erythromycin (substance)	Inferred relationship	Some	1
følsomhed over for erythromycin	Causative agent	False	Erythromycin (substance)	Inferred relationship	Some	1
Product containing erythromycin in ophthalmic dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Allergy to erythromycin	Causative agent	True	Erythromycin (substance)	Inferred relationship	Some	1
Erythromycin 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some	1
Erythromycin 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erythromycin (substance)	Inferred relationship	Some	1
Erythromycin (as erythromycin stearate) 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erythromycin (substance)	Inferred relationship	Some	1
Erythromycin dihydrate (substance)	Is a	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin propionate (substance)	Is a	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin lactobionate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Erythromycin (substance)	Inferred relationship	Some
Erythromycin dihydrate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Erythromycin (substance)	Inferred relationship	Some
Erythromycin phosphate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Erythromycin (substance)	Inferred relationship	Some
Erythromycin propionate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Erythromycin (substance)	Inferred relationship	Some
Erythromycin stearate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Erythromycin (substance)	Inferred relationship	Some
Erythromycin gluceptate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Erythromycin (substance)	Inferred relationship	Some
Erythromycin ethylsuccinate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Erythromycin (substance)	Inferred relationship	Some
Erythromycin estolate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Erythromycin (substance)	Inferred relationship	Some
Erythromycin 250mg gastro-resistant oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Erythromycin (substance)	Inferred relationship	Some
Erythromycin 250 mg gastro-resistant oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erythromycin (substance)	Inferred relationship	Some	1
Erythromycin 250 mg gastro-resistant oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erythromycin (substance)	Inferred relationship	Some	1
Erythromycin 500 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin (as erythromycin lactobionate) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 100 milligram/1 milliliter conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 25 milligram/1 milliliter conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin 20 milligram/1 gram conventional release cutaneous gel (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Erythromycin (substance)	Inferred relationship	Some	2
Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Erythromycin (substance)	Inferred relationship	Some	2
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Erythromycin (substance)	Inferred relationship	Some	2
Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Erythromycin (substance)	Inferred relationship	Some	2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Erythromycin (substance)	Inferred relationship	Some	2
Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Erythromycin (substance)	Inferred relationship	Some	2
Product containing erythromycin and sulfafurazole (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Erythromycin (substance)	Inferred relationship	Some	1
Erythromycin-containing product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Erythromycin (substance)	Inferred relationship	Some	1
Product containing erythromycin in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Erythromycin (substance)	Inferred relationship	Some	1

Page 1 of 2 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1197989013	Erythromycin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1211218019	Erythromycin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2476718017	Erythromycin base	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4490621000005110	Erythromycin	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)